Atlas Trials

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

Clinical trial NCT01890993 · COMPLETED

Trial details

NCT number
NCT01890993
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2013-08-01
Primary completion
2014-06-01
Enrollment
952

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.